does tirzepatide make you not want to drink alcohol Semaglutide and reduce consumption in individuals with obesity Could a medication used for

5 Much of this evidence comes from observational data, so more research is needed to fully understand the reason why

GLP-1 RAs help manage these interconnected chronic conditions

Internal projections suggest that annual approved claim costs for GLP-1 weight loss will eclipse $100 million for 2024 and grow to more than $170 million in 2025 for this market segment

Theres a lot of hype, and even more confusion, especially around compounded GLP-1s, brand-name meds like Wegovy, and what actually works for your goals

Gut Microbiome and GLP-1 Agonists: A review in the Journal of Endocrinological Investigation explored the interaction between GLP-1 agonists like semaglutide and the gut microbiome